Anoctamin 1, Calcium Activated Chloride Channel (ANO1) (Middle Region) Peptide
Quick Overview for Anoctamin 1, Calcium Activated Chloride Channel (ANO1) (Middle Region) Peptide (ABIN985220)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-TMEM16A antibody (Catalog #: ARP42506_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ANO1 (Anoctamin 1, Calcium Activated Chloride Channel (ANO1))
-
Background
-
TMEM16A belongs to the anoctamin family. TMEM16A acts as a calcium-activated chloride channel. It is required for normal tracheal development.
Alias Symbols: FLJ10261, ORAOV2, TAOS2, CACC, DOG1, TMEM16A
Protein Size: 960 -
Molecular Weight
- 111 kDa
-
Gene ID
- 55107
-
NCBI Accession
- NM_018043, NP_060513
-
UniProt
- Q5XXA6
Target
-